Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.
Tashiro
S
S
Maeda
H
H
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D003287:Contrast Media; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D007269:Injections, Intra-Arterial; D007459:Iodized Oil / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D008299:Maleic Anhydrides / Q000008:administration & dosage / Q000627:therapeutic use*; D011137:Polystyrenes / Q000008:administration & dosage / Q000627:therapeutic use*; D011859:Radiography; D009353:Zinostatin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003287:Contrast Media; D005663:Furans; D008299:Maleic Anhydrides; D011137:Polystyrenes; C035755:poly(maleic acid-styrene)neocarzinostatin; D007459:Iodized Oil; D009353:Zinostatin